Clinical Trial

Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease

Study acronym: GENOSS SES
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 16, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Efficacy and Safety of GENOSS SES in patients with coronary artery disease
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-18.
Trial Details
NCT Number NCT06841510
Lead Sponsor Genoss Co., Ltd.
Conditions Coronary Arterial Disease (CAD)
Enrollment 1,118 participants
Start Date 2018-04-19
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-16